Research output per year
Research output per year
Personal profile
Research interests
- Study of different aspects of the human immune response in health and disease
- Immune response to infectious agents (e.g. SARS-CoV-2) and non-infectious conditions (e.g. cancers)
- Cytokine profiling, antibody response studies, exosome research
Related documents
Fingerprint
Dive into the research topics where Vimvara Vacharathit is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cytokine and chemokine kinetics in natural human dengue infection as predictors of disease outcome
DENFREE Thailand, Dec 2025, In: Scientific Reports. 15, 1, 15612.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Persistent IP-10/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes
Vacharathit, V., Pluempreecha, M., Manopwisedjaroen, S., Srisaowakarn, C., Srichatrapimuk, S., Sritipsukho, P., Sritipsukho, N. & Thitithanyanont, A., Sept 2025, In: Clinical Immunology. 278, 110507.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells
Purwono, P. B., Vacharathit, V., Manopwisedjaroen, S., Ludowyke, N., Suksatu, A. & Thitithanyanont, A., Apr 2024, In: PLoS ONE. 19, 4 April, e0301330.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
CoronaVac induces lower neutralising activity against variants of concern than natural infection
Vacharathit, V., Aiewsakun, P., Manopwisedjaroen, S., Srisaowakarn, C., Laopanupong, T., Ludowyke, N., Phuphuakrat, A., Setthaudom, C., Ekronarongchai, S., Srichatrapimuk, S., Wongsirisin, P., Sangrajrang, S., Imsuwansri, T., Kirdlarp, S., Nualkaew, S., Sensorn, I., Sawaengdee, W., Wichukchinda, N., Sungkanuparph, S. & Chantratita, W. & 4 others, , Oct 2021, In: The Lancet Infectious Diseases. 21, 10, p. 1352-1354 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access60 Citations (Scopus) -
SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
Vacharathit, V., Srichatrapimuk, S., Manopwisedjaroen, S., Kirdlarp, S., Srisaowakarn, C., Setthaudom, C., Inrueangsri, N., Pisitkun, P., Kunakorn, M., Hongeng, S., Sungkanuparph, S. & Thitithanyanont, A., Nov 2021, In: International Journal of Infectious Diseases. 112, p. 227-234 8 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Citations (Scopus)